The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Evaluating the agreement between the empirical volumes of tumor lesions and the estimated volumes of tumor lesions based on the longest diameter.
Ruediger P. Laubender
Research Funding - Merck KGaA
Other Remuneration - Merck KGaA
Michael Schlichting
Employment or Leadership Position - Merck KGaA
Ute Sartorius
Employment or Leadership Position - Merck KGaA
Dominik Paul Modest
Other Remuneration - Merck KGaA
Ulrich Robert Mansmann
Research Funding - Merck KGaA
Volker Heinemann
Consultant or Advisory Role - Merck KGaA; Roche; Sanofi
Honoraria - Merck KGaA; Roche; Sanofi
Expert Testimony - Merck KGaA; Roche
Other Remuneration - Merck KGaA; Roche
Anno Graser
Consultant or Advisory Role - Siemans (U)
Honoraria - Bracco; Siemens Healthcare Diagnostics